Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI)

Pharmaceutical Preparations

https://www.ranitherapeutics.com

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.

2051 RINGWOOD AVENUE
SAN JOSE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/30/2021

Market Cap

147,667,770

Shares Outstanding

25,880,000

Weighted SO

25,880,064

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

VINC --.--%

TNYA --.--%

CRVS --.--%

ALXO --.--%

LYRA --.--%

TRVI --.--%

SQZ --.--%

TARA --.--%

TCON --.--%

Beta

0.1490

Last Div

0.0000

Range

1.82-8.75

Chg

0.0850

Avg Vol

57379

Mkt Cap

147667770

Exch

NASDAQ

Country

US

Phone

408 457 3700

DCF Diff

3.6906

DCF

-0.9306

Div Yield

0.0000

P/S

53.6974

EV Multiple

-3.1611

P/FV

25.6740

Div Yield %

0.0000

P/E

-2.3799

PEG

-0.0476

Payout

0.0000

Current Ratio

1.9320

Quick Ratio

1.9320

Cash Ratio

0.3024

DSO

13.2727

DIO

0.0000

Op Cycle

13.2727

DPO

152.8891

CCC

-139.6163

Gross Margin

0.5607

Op Margin

-21.0353

Pretax Margin

-22.0098

Net Margin

-11.1211

Eff Tax Rate

0.4947

ROA

-0.6994

ROE

-3.0092

ROCE

-2.1310

NI/EBT

0.5053

EBT/EBIT

1.0463

EBIT/Rev

-21.0353

Debt Ratio

0.7058

D/E

10.8854

LT Debt/Cap

0.8585

Total Debt/Cap

0.9159

Int Coverage

-21.9951

CF/Debt

-1.4651

Equity Multi

15.4236

Rec Turnover

27.5000

Pay Turnover

2.3874

Inv Turnover

0.0000

FA Turnover

0.2403

Asset Turnover

0.0629

OCF/Share

-1.7175

FCF/Share

-1.7463

Cash/Share

1.1929

OCF/Sales

-16.4407

FCF/OCF

1.0168

CF Coverage

-1.4651

ST Coverage

-3.3115

CapEx Coverage

-59.6464

Div&CapEx Cov

-59.6464

P/BV

25.6740

P/B

25.6740

P/S

53.6974

P/E

-2.3799

P/FCF

-3.2123

P/OCF

-1.6099

P/CF

-1.6099

PEG

-0.0476

P/S

53.6974

EV Multiple

-3.1611

P/FV

25.6740

DPS

0.0000

Latest Headlines (EST)

Benzinga Nov 09, 13:00 Analyst Ratings for Rani Therapeutics Hldgs

Revenue Product Segmentation